The American College of Cardiology (ACC) has issued guidance to help clinicians and patients use health data collected while wearing Apple Watch to effectively track and manage cardiovascular health. ...

The quality of a low-carbohydrate or low-fat diet may matter more than the amount of carbohydrates or fat consumed when it comes to reducing heart disease risk, according to a new study published in ...

The Society for Cardiovascular Angiography & Interventions (SCAI), American College of Cardiology (ACC), and Society of Thoracic Surgeons (STS), on May 1, released the following joint statement in ...

The ACC is pleased to announce the recipients of its 2026 Distinguished Awards. This year's honorees represent an exceptional group of individuals whose past and ongoing efforts have made meaningful ...

About 50% of U.S. adults will develop high BP during their lifetime. High BP is the most prevalent and modifiable risk factor for cardiovascular disease and all-cause mortality. The overarching BP ...

Among patients with severe left ventricular (LV) dysfunction and severe coronary heart disease undergoing complex PCI, elective LV unloading with a microaxial flow pump did not reduce the risk of ...

Spironolactone, an aldosterone blocker, compared with placebo, did not show any significant improvement in terms of heart failure (HF) hospitalizations and cardiovascular death at 24 months in ...

Until about 15 years ago, most cardiologists were found in private practices, where the physicians – usually in groups – owned the practice and had privileges for hospital-based services at one or ...

The Dietary Guidelines for Americans (DGA), released every five years by the U.S. Department of Health and Human Services and U.S. Department of Agriculture, are a major driver of U.S. food policy, ...

Artificial intelligence (AI) is increasingly touching more aspects of modern life, offering great promise, but also great risk. The great potential and concerning influences of AI on medicine, ...

Device-based left atrial appendage (LAA) closure was comparable to non-vitamin K antagonist oral anticoagulant (NOAC) therapy in reducing the combined rate of death from cardiovascular causes, stroke, ...

Semaglutide, the popular anti-obesity medication originally developed to treat diabetes, continues to show cardiovascular benefits beyond weight loss, including reducing risk of death, reducing ...